@article{867a7043d6c847bba9a1837aa98bebe4,
title = "MicroRNA miR-181a/b-1 controls MAIT cell development",
abstract = "Mucosal-associated invariant T (MAIT) cells constitute a major fraction of innate-like T cells in humans with critical roles in defense against microbial pathogens and in maintaining mucosal integrity. However, the molecular mechanisms underlying MAIT cell development remain largely elusive. Here we investigated the role of miR-181a/b-1, a pair of microRNAs that serve as rheostat of TCR signal strength, in this process. Loss of miR-181a/b-1 in mice resulted in a profound arrest in early MAIT cell development. As a consequence, in the absence of miR-181a/b-1, thymic MAIT cells failed to acquire functional maturity based on expression of transcription factors PLZF, T-bet and RORγt. Temporal analysis of development using a molecular timer in combination with loss of miR-181a/b-1 revealed that MAIT cells complete functional maturation in the periphery and indicates that functionally mature MAIT cells in the thymus are long-term resident cells. Thus, our study provides insight into the dynamics of MAIT cell development in vivo. Of note, deletion of miR-181a/b-1 alone completely mirrored loss of all miRNAs.",
keywords = "Development, MAIT cell, miR-181, miRNA, thymus",
author = "Winter, {Samantha J.} and Heike Kunze-Schumacher and Esther Imelmann and Zoe Grewers and Tabea Osthues and Andreas Krueger",
note = "Funding Information: Rag1GFP knock-in mice were kindly provided by Dr Jochen Huehn (HZI Braunschweig). We thank Dr Olivier Lantz for providing the Vα19Jα33 TCRα sequence. MR1-5-OP-RU tetramer technology was developed jointly by Dr James McCluskey, Dr Jamie Rossjohn and Dr David Fairlie, and the material was produced by the NIH Tetramer Core Facility as permitted to be distributed by the University of Melbourne. This work was funded by grants from the German Research Foundation (DFG) KR2320/5-1 and SFB902-B15 (to AK). Funding Information: Rag1GFP knock-in mice were kindly provided by Dr Jochen Huehn (HZI Braunschweig). We thank Dr Olivier Lantz for providing the Vα19Jα33 TCRα sequence. MR1-5-OP-RU tetramer technology was developed jointly by Dr James McCluskey, Dr Jamie Rossjohn and Dr David Fairlie, and the material was produced by the NIH Tetramer Core Facility as permitted to be distributed by the University of Melbourne. This work was funded by grants from the German Research Foundation (DFG) KR2320/5-1 and SFB902-B15 (to AK). The authors declare that no conflict of interest exists. Publisher Copyright: {\textcopyright} 2018 Australasian Society for Immunology Inc.",
year = "2019",
month = feb,
doi = "10.1111/imcb.12211",
language = "English",
volume = "97",
pages = "190--202",
journal = "Immunology & Cell Biology",
issn = "0818-9641",
publisher = "Nature Publishing Group - Macmillan Publishers",
number = "2",
}